IL146023A0 - Novel synthesis and crystallization of piperazine ring-containing compounds - Google Patents

Novel synthesis and crystallization of piperazine ring-containing compounds

Info

Publication number
IL146023A0
IL146023A0 IL14602300A IL14602300A IL146023A0 IL 146023 A0 IL146023 A0 IL 146023A0 IL 14602300 A IL14602300 A IL 14602300A IL 14602300 A IL14602300 A IL 14602300A IL 146023 A0 IL146023 A0 IL 146023A0
Authority
IL
Israel
Prior art keywords
crystallization
containing compounds
piperazine ring
novel synthesis
synthesis
Prior art date
Application number
IL14602300A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL146023A0 publication Critical patent/IL146023A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL14602300A 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds IL146023A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13004799P 1999-04-19 1999-04-19
PCT/US2000/010357 WO2000062782A1 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds

Publications (1)

Publication Number Publication Date
IL146023A0 true IL146023A0 (en) 2002-07-25

Family

ID=22442814

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14602300A IL146023A0 (en) 1999-04-19 2000-04-18 Novel synthesis and crystallization of piperazine ring-containing compounds

Country Status (16)

Country Link
JP (1) JP2004500324A (enExample)
KR (1) KR20020019902A (enExample)
CN (4) CN1679586A (enExample)
CA (1) CA2368815A1 (enExample)
CZ (1) CZ20013658A3 (enExample)
HK (1) HK1044116A1 (enExample)
HR (1) HRP20010747A2 (enExample)
HU (1) HUP0200839A3 (enExample)
IL (1) IL146023A0 (enExample)
PL (1) PL366289A1 (enExample)
RU (1) RU2001128229A (enExample)
SK (1) SK14672001A3 (enExample)
TR (1) TR200103028T2 (enExample)
WO (1) WO2000062782A1 (enExample)
YU (1) YU74101A (enExample)
ZA (1) ZA200108220B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001038329A1 (en) * 1999-11-24 2001-05-31 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine crystals and process for producing the same
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
US6660730B2 (en) * 2000-11-27 2003-12-09 Sumika Fine Chemicals Co., Ltd. Anhydrous mirtazapine and process for preparing the same
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
ES2246161B1 (es) * 2004-07-22 2007-04-01 Medichem, S.A. Proceso mejorado para la fabricacion de mirtazapina.
JP4848704B2 (ja) * 2004-08-24 2011-12-28 住友化学株式会社 2−(4−メチル−2−フェニルピペラジン−1−イル)−3−シアノピリジンの製造方法
JP5192707B2 (ja) 2007-03-22 2013-05-08 住友化学株式会社 ミルタザピンの製造方法
US7994314B2 (en) 2007-04-11 2011-08-09 N.V. Organon Method for the preparation of an enantiomerically pure benzazepine
WO2008125578A2 (en) 2007-04-11 2008-10-23 N.V. Organon A method for the preparation of mirtazapine
KR101485418B1 (ko) 2013-05-29 2015-01-26 주식회사 메디켐코리아 고순도 미르타자핀의 제조방법
JP2017088564A (ja) * 2015-11-13 2017-05-25 株式会社トクヤマ ミルタザピンの製造方法
JP6571497B2 (ja) * 2015-11-13 2019-09-04 株式会社トクヤマ ミルタザピンの製造方法
CN108191873B (zh) * 2018-01-08 2021-09-24 山东省食品药品检验研究院 一种盐酸米安色林的纯化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.

Also Published As

Publication number Publication date
CZ20013658A3 (cs) 2002-08-14
CN1680374A (zh) 2005-10-12
HRP20010747A2 (en) 2002-12-31
CA2368815A1 (en) 2000-10-26
CN1679586A (zh) 2005-10-12
ZA200108220B (en) 2006-02-26
WO2000062782A1 (en) 2000-10-26
HUP0200839A3 (en) 2003-05-28
JP2004500324A (ja) 2004-01-08
HUP0200839A2 (en) 2002-08-28
SK14672001A3 (sk) 2002-11-06
RU2001128229A (ru) 2003-07-10
PL366289A1 (en) 2005-01-24
YU74101A (sh) 2004-09-03
CN1356903A (zh) 2002-07-03
TR200103028T2 (tr) 2002-01-21
CN1680365A (zh) 2005-10-12
KR20020019902A (ko) 2002-03-13
HK1044116A1 (zh) 2002-10-11

Similar Documents

Publication Publication Date Title
IL149592A0 (en) Synthesis of 2'-deoxy-l-nucleosides
HUP0203431A3 (en) Novel heterocyclic compounds and salts thereof and pharmaceutical compositions containing and use of the same
CZ20011657A3 (cs) Nové piperazinové a piperidinové sloučeniny, způsob jejich přípravy a jejich pouľití
AU3771100A (en) Synthesis of epothilones
IL146023A0 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
PL346544A1 (en) Crystalline forms of eto2
HUP0202255A3 (en) Crystalline 1-methylcarbapenem compounds and pharmaceutical compositions containing them
NO20023072L (no) Syntese av krystallinske silikoaluminofosfater
HUP0201714A3 (en) Substituted heterocyclic compounds and pharmaceutical compositions containing them
PL342817A1 (en) Novel derivatives of dihydroxyhexanic acid
IL140492A (en) Crystalline polymorph of ritonavir
HUP0204069A3 (en) Novel processes for making- and a new crystalline form of- leflunomide and pharmaceutical composition containing it
AU2001269685A1 (en) Crystallization of 4-diphosphocytidyl-2-c-methylerythritol synthesis
IL139946A (en) Chemical synthesis of morpholine derivatives
GB9909756D0 (en) Synthesis of polycarbonates
IL146024A0 (en) Novel synthesis of piperazine ring
GB9914253D0 (en) Synthesis of substitiuted amidines
PL345999A1 (en) Crystalline forms of osanetant
EP1178805A4 (en) NOVEL SYNTHESIS AND CRYSTALLIZATION OF PIPERAZINE-CONTAINING COMPOUNDS
IL138647A0 (en) Synthesis of compounds and libraries of compounds
HUP0004755A3 (en) Polymorphic forms of crystalline roxifiban and pharmaceutical compositions containing them
GB0011407D0 (en) Synthesis of substituted prolines
AU1822500A (en) Synthesis of 4-ketocyclopentene and cyclopentadiene compounds
IL137918A0 (en) Solid support synthesis of 2-oxopiperazines
AU4015900A (en) Synthesis of epoxy-thf compounds